Seven Europe-based drug firms have announced plans to pool their research efforts together with universities and smaller companies in a project which aims to develop tomorrow’s medicines. The European Lead Factory (ELF), backed by the EU, is backed by €196m ($265m). €80m ($107m) is being provided by the European Commission’s Seventh Framework Programme for Research…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.